Securities Report – 81st Fiscal Period (April 1, 2025 – March 31, 2026)
NQ Score
73/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Kissei Pharmaceutical Co., Ltd. has published its securities report for the 81st fiscal period (April 1, 2025 – March 31, 2026), disclosing key financial information including business performance, financial position, and future outlook to investors.
AI Analysis
Frequently Asked Questions
- Q: When does Kissei Pharmaceutical's 81st fiscal period start?
- A: It runs from April 1, 2025 to March 31, 2026.
- Q: Where can I find the securities report?
- A: It is available on the company's official website or Japan's EDINET.
- Q: What are Kissei Pharmaceutical's main products?
- A: Key products include Celecoxib, Allelion, and Rize.